Chapter 001
Neovascular age-related macular degeneration (nAMD)
Diagnosis, activity assessment, and individualized anti-VEGF treatment—with exam- and practice-relevant limits of the evidence.
Existing published version
Ophthalmology · 214 chapters
Browse by specialty or search by topic and chapter number. Every chapter is available in English, German and Arabic.
Newly published chapters are working copies. Their source, translation and medical checks remain explicitly open. These materials support learning and do not replace individual medical assessment.
214 chapters shown
No matching chapters. Change your search or reset the filters.
Chapter 001
Diagnosis, activity assessment, and individualized anti-VEGF treatment—with exam- and practice-relevant limits of the evidence.
Existing published version
Chapter 002
Clinical grading of NPDR and PDR, appropriate imaging, screening, and stage-based treatment—with diabetic macular oedema assessed separately.
Existing published version
Chapter 003
Existing version · revision deferred
Chapter 014
Combine the clinical pattern with retinal function and genetic evidence; look for treatable mimics and systemic disease.
Working copy · review pending
Chapter 015
Start with the central retinal defect, then connect the repair to its evidence and the person’s needs. Retained broader surgical topics are clearly separated by indication.
Working copy · review pending
Chapter 017
A complete teaching review of retinal vein occlusion, with the retained arterial occlusion, giant cell arteritis, neovascular glaucoma and PAMM chapters.
Working copy · review pending
Chapter 018
Acute arterial retinal ischaemia needs immediate eye and stroke assessment. The complete original vascular lecture also retains venous occlusion, neovascular glaucoma, giant cell arteritis and PAMM for comparison.
Working copy · review pending
Chapter 019
A complete teaching draft covering retinal development, classification, screening, examination, treatment and long-term care. National screening schedules and drug-specific treatment rules must be distinguished.
Working copy · review pending
Chapter 020
From acute flashes and floaters to the retinal examination, tear prophylaxis and selection of buckle, vitrectomy or pneumatic retinopexy. The complete original lecture also retains complex vitreoretinal techniques and non-rhegmatogenous differentials.
Working copy · review pending
Chapter 029
Longer intervals may reduce burden when visual function and disease control are maintained. PULSAR, extension data, teaching cases and systemic hypotheses address different questions and are appraised separately.
Working copy · review pending
Chapter 030
Vascular permeability, inflammation and altered cellular function interact in DME. OCT describes findings and course but does not alone determine the better therapy; study results and unconfirmed lecture claims are distinguished.
Working copy · review pending
Chapter 039
Read fluid and tissue together with vision and disease context. A useful measurement is not automatically a validated treatment-selection tool.
Working copy · review pending
Chapter 046
Recognise retinal mimics of optic neuropathy and investigate possible systemic disease.
Working copy · review pending
Chapter 075
Assess acuity, symptoms and OCT together. Stable useful vision may permit observation; progressive loss needs a vitreoretinal discussion. Neither subretinal fluid nor a named flap dictates one operation.
Working copy · review pending
Chapter 086
A briefing-style lecture connects treatment burden, the PULSAR trial and two teaching cases. Non-inferiority, interval figures, drying endpoints and systemic hypotheses answer different questions and are appraised separately.
Working copy · review pending
Chapter 092
Read the fundus as one part of a systemic assessment. Recognise hypertensive damage, separate vein occlusion from artery occlusion, and treat the complication that threatens vision or the fellow eye.
Working copy · review pending
Chapter 099
Separate the molecular rationale, randomised nAMD evidence and real-world follow-up. Longer injection intervals do not automatically establish fewer visits, better adherence or safe treatment cessation.
Working copy · review pending
Chapter 101
DME and RVO share treatment tools but differ in natural history, trial populations and monitoring. Choose treatment from centre involvement, visual function and cause, then individualise response-based follow-up.
Working copy · review pending
Chapter 106
Assess vision, centre involvement, treatment exposure and the whole patient before changing DME treatment.
Working copy · review pending
Chapter 110
A gas bubble can close selected retinal breaks while retinopexy creates adhesion. Selection, sterile technique, perfusion and positioning determine whether this approach is appropriate.
Working copy · review pending
Chapter 113
Most inherited retinal diseases are not syndromic, but the minority that are can change the whole patient. A structured history, multimodal imaging and the right referrals matter more than a rapid syndrome label.
Working copy · review pending
Chapter 115
Combine the clinical pattern with retinal function and genetic evidence; look for treatable mimics and systemic disease.
Working copy · review pending
Chapter 121
A pit is not the same as macular fluid. Separate prevalence from incidence, describe schisis and subretinal fluid precisely, and let vision, foveal risk and follow-up decide observation or surgery.
Working copy · review pending
Chapter 122
Name the leading sign, exclude the dangerous differential and state what imaging and evidence can actually support.
Working copy · review pending
Chapter 123
Read the stage, decide whether the macula or the ischaemic drive is the problem, and treat the systemic disease alongside — with the limits of each study kept visible.
Working copy · review pending
Chapter 135
Use vitreoretinal anatomy and multimodal imaging to explain findings, with attention to artefacts and the limits of each method.
Working copy · review pending
Chapter 136
Read the haemorrhage and ischaemic pattern with its systemic context before choosing observation, imaging or intervention.
Working copy · review pending
Chapter 137
Separate the molecular rationale, randomised nAMD evidence and real-world follow-up. Longer injection intervals do not automatically establish fewer visits, better adherence or safe treatment cessation.
Working copy · review pending
Chapter 139
Reduce treatment burden through response-guided intervals while keeping function, safety and follow-up in view.
Working copy · review pending
Chapter 146
From acute flashes and floaters to the retinal examination, tear prophylaxis and selection of buckle, vitrectomy or pneumatic retinopexy. The complete original lecture also retains complex vitreoretinal techniques and non-rhegmatogenous differentials.
Working copy · review pending
Chapter 147
From acute flashes and floaters to the retinal examination, tear prophylaxis and selection of buckle, vitrectomy or pneumatic retinopexy. The complete original lecture also retains complex vitreoretinal techniques and non-rhegmatogenous differentials.
Working copy · review pending
Chapter 159
Assess acuity, symptoms and OCT together. Stable useful vision may permit observation; progressive loss needs a vitreoretinal discussion. Neither subretinal fluid nor a named flap dictates one operation.
Working copy · review pending
Chapter 160
Assess acuity, symptoms and OCT together. Stable useful vision may permit observation; progressive loss needs a vitreoretinal discussion. Neither subretinal fluid nor a named flap dictates one operation.
Working copy · review pending
Chapter 162
Read fluid and tissue together with vision and disease context. A useful measurement is not automatically a validated treatment-selection tool.
Working copy · review pending
Chapter 168
Read the stage, decide whether the macula or the ischaemic drive is the problem, and treat the systemic disease alongside — with the limits of each study kept visible.
Working copy · review pending
Chapter 173
Read the fundus as one part of a systemic assessment. Recognise hypertensive damage, separate vein occlusion from artery occlusion, and treat the complication that threatens vision or the fellow eye.
Working copy · review pending
Chapter 175
Read the fundus as one part of a systemic assessment. Recognise hypertensive damage, separate vein occlusion from artery occlusion, and treat the complication that threatens vision or the fellow eye.
Working copy · review pending
Chapter 178
Start with the cause, central vision and OCT, then agree a treatment and monitoring schedule the patient can attend.
Working copy · review pending
Chapter 180
Recognise the retinal pattern, establish the exact exposure and coordinate the response with the prescribing team.
Working copy · review pending
Chapter 181
A complete teaching review of retinal vein occlusion, with the retained arterial occlusion, giant cell arteritis, neovascular glaucoma and PAMM chapters.
Working copy · review pending
Chapter 183
Separate early/intermediate AMD, atrophy and active neovascular disease before discussing prevention or injections.
Working copy · review pending
Chapter 184
Separate early/intermediate AMD, atrophy and active neovascular disease before discussing prevention or injections.
Working copy · review pending
Chapter 185
Separate an acute retinal-break risk from chronic interface disease and medicine-related outer retinal injury.
Working copy · review pending
Chapter 186
Separate peripheral proliferative disease, macular ischaemia and oedema before selecting treatment.
Working copy · review pending
Chapter 189
A calm guide to a childhood emergency, an adult malignancy and their mimics: what the examination shows, what imaging adds, and where the evidence stops.
Working copy · review pending
Chapter 192
Choose the access, instrument and tamponade from the retinal problem and the actual safety requirements.
Working copy · review pending
Chapter 197
Distinguish refractive severity from structural disease and assess each lesion rather than relying on one axial-length threshold.
Working copy · review pending
Chapter 199
Use the diagnosis, traction, lens status and actual anatomy to choose the operation and postoperative plan.
Working copy · review pending
Chapter 200
Use the diagnosis, traction, lens status and actual anatomy to choose the operation and postoperative plan.
Working copy · review pending
Chapter 201
Distinguish a paraneoplastic syndrome, uveal effusion, haemangioma and central serous chorioretinopathy before choosing treatment.
Working copy · review pending
Chapter 202
Choose the access, instrument and tamponade from the retinal problem and the actual safety requirements.
Working copy · review pending
Chapter 204
Read the haemorrhage and ischaemic pattern with its systemic context before choosing observation, imaging or intervention.
Working copy · review pending
Chapter 208
Separate early/intermediate AMD, atrophy and active neovascular disease before discussing prevention or injections.
Working copy · review pending
Chapter 209
Read the stage, decide whether the macula or the ischaemic drive is the problem, and treat the systemic disease alongside — with the limits of each study kept visible.
Working copy · review pending
Chapter 211
A complete teaching draft covering retinal development, classification, screening, examination, treatment and long-term care. National screening schedules and drug-specific treatment rules must be distinguished.
Working copy · review pending
Chapter 212
Connect symptoms, peripheral examination and mechanism before treatment.
Working copy · review pending
Chapter 213
Use the clinical pattern to select tests, explain uncertainty and treat useful targets.
Working copy · review pending
Chapter 216
A complete teaching draft on Coats disease, macular telangiectasia and the ocular phakomatoses. The original lecture structure, tables, numbers, questions and patient sections are kept, and the places where the original wording needs clinical qualification are marked.
Working copy · review pending
Chapter 217
A complete teaching draft built on the second original lecture: the Shields stage table, the Coats versus retinoblastoma comparison, the neurofibromatosis comparison of NF1 and NF2, the examination dashboard and all original numbers are kept. Areas where the original wording needs clinical qualification are marked.
Working copy · review pending
Chapter 218
Leukocoria and suspicious childhood ocular inflammation need specialist tumour assessment before intraocular intervention.
Working copy · review pending
Chapter 223
Read the fundus as one part of a systemic assessment. Recognise hypertensive damage, separate vein occlusion from artery occlusion, and treat the complication that threatens vision or the fellow eye.
Working copy · review pending
Chapter 226
A complete teaching draft covering retinal development, classification, screening, examination, treatment and long-term care. National screening schedules and drug-specific treatment rules must be distinguished.
Working copy · review pending
Chapter 227
Pachychoroid describes a spectrum of choroidal vascular and overlying retinal changes. The proposed mechanisms do not establish one obligatory sequence for every eye.
Working copy · review pending
Chapter 231
Geographic atrophy is late age-related macular degeneration with loss of RPE, photoreceptors and choriocapillaris; define it with the CAM cRORA criteria, not with a single RPE-loss size.
Working copy · review pending
Chapter 004
From aqueous outflow and target pressure to procedure selection, evidence appraisal and postoperative care.
Existing published version
Chapter 005
A practical lecture for ophthalmology training: examine the disc, read OCT and fields, measure pressure and plan follow-up.
Existing published version
Chapter 006
A complete practical lecture: prepare the test, read the report, choose the grid and assess change carefully.
Existing published version
Chapter 007
Complete lecture with teaching cases, comparison table and explicit source questions.
Working copy · review pending
Chapter 008
A complete teaching lecture on ALT, SLT, DSLT, peripheral iridotomy, iridoplasty and cyclophotocoagulation.
Working copy · review pending
Chapter 009
Choose a pressure-lowering treatment that the patient can use safely, then judge its effect against structural and functional follow-up.
Working copy · review pending
Chapter 010
Assess the optic nerve, visual field and pressure together. Keep evidence for NTG separate from the original lecture’s broader laser, MIGS and vitreoretinal-surgery examples.
Working copy · review pending
Chapter 011
Assess pressure, optic nerve, visual field and angle together. Distinguish POAG from secondary disease and choose treatment for the individual risk.
Working copy · review pending
Chapter 012
Distinguish pigment dispersion from glaucoma. Keep the broader original secondary-glaucoma examples in context and plan pressure control,causal treatment and monitoring together.
Working copy · review pending
Chapter 013
Recognise the emergency first, then distinguish anatomical risk from glaucoma and choose treatment for the actual mechanism.
Working copy · review pending
Chapter 026
Combine pressure, visual fields and anatomy; separate promising associations from validated clinical decisions.
Working copy · review pending
Chapter 053
Combine pressure, cornea, optic nerve, refraction and growth; interpret each measurement under its actual examination conditions.
Working copy · review pending
Chapter 095
Primary congenital glaucoma is rare and usually needs surgery. Choose the angle operation from anatomy and corneal clarity, appraise the limited comparative evidence cautiously, and plan lifelong pressure, vision and amblyopia follow-up.
Working copy · review pending
Chapter 112
Assess symptoms, tear film, cornea and treatment use together before choosing a better tolerated regimen.
Working copy · review pending
Chapter 114
Assess pressure, optic nerve, visual field and angle together. Distinguish POAG from secondary disease and choose treatment for the individual risk.
Working copy · review pending
Chapter 119
Distinguish pigment dispersion from glaucoma. Keep the broader original secondary-glaucoma examples in context and plan pressure control,causal treatment and monitoring together.
Working copy · review pending
Chapter 126
After surgery, measure visual function and treat refractive error and amblyopia alongside continuing glaucoma surveillance.
Working copy · review pending
Chapter 128
Read the study design and patient selection before turning a result into a treatment rule. These 2024–2025 papers address medication, laser and filtering surgery.
Working copy · review pending
Chapter 130
Ask about symptoms and daily drop burden, examine the surface and adjust pressure treatment and surface care together.
Working copy · review pending
Chapter 133
Plan a complete, age-appropriate assessment rather than diagnosing from a single pressure or OCT colour.
Working copy · review pending
Chapter 141
Combine pressure, ocular growth, cornea and optic nerve; choose treatment for the glaucoma type rather than a single threshold.
Working copy · review pending
Chapter 142
Combine pressure, ocular growth, cornea and optic nerve; choose treatment for the glaucoma type rather than a single threshold.
Working copy · review pending
Chapter 156
Before adding treatment, ask how the drops are actually used. Discuss discomfort, technique, access and daily burden without blame.
Working copy · review pending
Chapter 161
Ask who needs examination, what a suspicious result means and when to repeat a negative screen. Distinguish the strength of a recommendation from the underlying evidence level.
Working copy · review pending
Chapter 165
Select treatment from target pressure, remaining nerve function, angle, retinal disease and follow-up capacity.
Working copy · review pending
Chapter 167
Check the test conditions before interpreting loss; combine repeated fields with optic nerve and OCT findings.
Working copy · review pending
Chapter 174
Ask who needs examination, what a suspicious result means and when to repeat a negative screen. Distinguish the strength of a recommendation from the underlying evidence level.
Working copy · review pending
Chapter 176
Glaucoma research reaches practice slowly. Separate a risk score from a diagnosis, and a research model from a validated clinical pathway.
Working copy · review pending
Chapter 177
Glaucoma research reaches practice slowly. Separate a risk score from a diagnosis, and a research model from a validated clinical pathway.
Working copy · review pending
Chapter 179
Control pressure while examining the ocular surface and the real treatment burden.
Working copy · review pending
Chapter 187
Choose the procedure from the clinical goal and evidence population, not from a device ranking.
Working copy · review pending
Chapter 188
Interpret morphology, function and pressure together; investigate disagreement before assigning a diagnosis.
Working copy · review pending
Chapter 196
Assess optic-nerve damage, pressure and the drainage angle together before selecting treatment.
Working copy · review pending
Chapter 203
Recognise the emergency first, then distinguish anatomical risk from glaucoma and choose treatment for the actual mechanism.
Working copy · review pending
Chapter 205
Pressure, chamber depth, wound/bleb findings and vision must be interpreted together. Both high and low pressure can threaten sight.
Working copy · review pending
Chapter 206
Choose surgery from documented progression, target pressure and the risks of the actual eye. Technical examples require individual planning and specialist training.
Working copy · review pending
Chapter 207
A complete teaching lecture on ALT, SLT, DSLT, peripheral iridotomy, iridoplasty and cyclophotocoagulation.
Working copy · review pending
Chapter 215
Choose a pressure-lowering treatment that the patient can use safely, then judge its effect against structural and functional follow-up.
Working copy · review pending
Chapter 221
Recognise the emergency first, then distinguish anatomical risk from glaucoma and choose treatment for the actual mechanism.
Working copy · review pending
Chapter 224
Identify the population, assess the finding and choose the appropriate screening or treatment pathway. Neonatal retinal development and adult optic-nerve risk require different evidence and follow-up.
Working copy · review pending
Chapter 225
Ask who needs examination, what a suspicious result means and when to repeat a negative screen. Distinguish the strength of a recommendation from the underlying evidence level.
Working copy · review pending
Chapter 062
When capsule support is inadequate, compare four IOL strategies by anatomy, complications and the surgeon's own experience.
Working copy · review pending
Chapter 063
Compare four fixation strategies, the sutureless techniques and the lens models discussed in the lecture, with their evidence limits.
Working copy · review pending
Chapter 079
Assess visual significance and systemic risk promptly. Surgery, optical correction, amblyopia treatment and lifelong follow-up form one care pathway; no fixed age or IOL target suits every child.
Working copy · review pending
Chapter 108
Treat combined cataract and glaucoma surgery as a staged clinical decision, not a default package. Target pressure, angle anatomy, previous filtering surgery and the actual trial population decide whether a minimally invasive procedure adds useful lowering or only complexity.
Working copy · review pending
Chapter 109
Posterior capsule rupture needs a structured response. Chamber stability, vitreous control and residual capsule and zonular support guide the next steps and later IOL fixation.
Working copy · review pending
Chapter 116
Coordinate the lens operation with the cornea, pupil, macula and proliferative disease. Prior injections change the risk assessment, not the diagnosis by themselves.
Working copy · review pending
Chapter 117
Coordinate the lens operation with the cornea, pupil, macula and proliferative disease. Prior injections change the risk assessment, not the diagnosis by themselves.
Working copy · review pending
Chapter 118
Axial length, chamber depth, pupil behaviour and zonular support change biometry and the surgical plan. Interpret thresholds and formula claims in the individual eye.
Working copy · review pending
Chapter 170
Compare four fixation strategies, the sutureless techniques and the lens models discussed in the lecture, with their evidence limits.
Working copy · review pending
Chapter 182
Describe the lesion, determine its depth and arrange the biopsy with the treating tumour team.
Working copy · review pending
Chapter 190
Phacoemulsification is a vacuum-controlled aspiration technique in which ultrasound is one tool, not the whole operation. Learn the sequence, the physics and the points where a remembered rule becomes a risk.
Working copy · review pending
Chapter 191
A toric lens corrects corneal astigmatism only as well as the measurement, the calculation and the alignment allow. Learn the decisions that matter, and treat remembered thresholds with care.
Working copy · review pending
Chapter 214
Separate corneal irregularity, endothelial failure and previous refractive surgery before choosing lens power or timing.
Working copy · review pending
Chapter 220
Follow the operation from incision to closure and distinguish principles from fixed rescue recipes.
Working copy · review pending
Chapter 232
This is a narrative evidence synthesis for adults with cataract and macular disease, focusing on AMD. It combines guidelines, a systematic review and mainly non-randomised primary studies. It is not a new systematic review. The questions concern functional benefit, possible AMD progression, reliable biometry and appropriate IOL optics. Early/intermediate AMD, neovascular AMD (nAMD) and geographic atrophy require separate assessment.
Working copy · review pending
Chapter 021
A vascularised conjunctival cover can support a threatened corneal surface. Decide first whether the priority is infection control, structural integrity, comfort or visual rehabilitation; those aims do not always lead to the same procedure.
Working copy · review pending
Chapter 023
A diagnosis-led step-ladder approach, with local treatment, systemic therapy and long-term safety.
Working copy · review pending
Chapter 024
Choose complementary images for the clinical question, then interpret them with the examination and disease course.
Working copy · review pending
Chapter 033
Localize the inflammation, identify infection and assess threatened vision before choosing immunosuppression. Behçet predominantly causes occlusive retinal inflammation, VKH choroiditis, and sarcoidosis variable granulomatous disease; their patterns overlap.
Working copy · review pending
Chapter 044
Describe the inflammation before selecting tests and treatment.
Working copy · review pending
Chapter 047
Describe the inflammation precisely, identify clues in the history and select investigations that change management.
Working copy · review pending
Chapter 048
Describe the inflammation precisely, identify clues in the history and select investigations that change management.
Working copy · review pending
Chapter 049
Describe the inflammation precisely, identify clues in the history and select investigations that change management.
Working copy · review pending
Chapter 055
Multimodal imaging connects the lesion pattern with its clinical course; a white spot alone does not define mechanism.
Working copy · review pending
Chapter 080
Paediatric uveitis is often asymptomatic and still causes permanent visual loss. Grade the cells in a dark room, classify the anatomy and the course, then look for the systemic association that changes management.
Working copy · review pending
Chapter 081
First establish whether inflammation is infectious, noninfectious or a masquerade. A detailed history and coordinated ocular/systemic assessment guide treatment; childhood uveitis is not invariably autoimmune.
Working copy · review pending
Chapter 082
Classify site, course and activity, then use the complete history and systemic findings to distinguish seven different clinical problems. A quiet-looking eye does not exclude inflammation, and a treatment response does not establish its cause.
Working copy · review pending
Chapter 087
Retinal vessel inflammation, ischaemia, masquerade disease and intraocular infection need different investigations. Use the phenotype to guide the next question, rather than treating it as proof of cause.
Working copy · review pending
Chapter 088
New or atypical uveitis in an older adult warrants a broad differential. Imaging raises suspicion; coordinated tissue diagnosis and systemic staging determine the next step.
Working copy · review pending
Chapter 111
In cataract with uveitis, inflammatory activity, associated damage and surgical anatomy guide management. A prepared, preferably quiet eye and close follow-up improve the conditions for surgery.
Working copy · review pending
Chapter 134
Describe the inflammatory phenotype, investigate the relevant causes and distinguish prevention from urgent treatment.
Working copy · review pending
Chapter 143
Cells, iris and corneal findings guide targeted assessment and follow-up.
Working copy · review pending
Chapter 144
Choose each test for a clinical question and each therapy for the disease and risk.
Working copy · review pending
Chapter 145
Connect direct ocular findings with systemic history and selected tests.
Working copy · review pending
Chapter 166
Assess acuity, inflammation, pressure, retina and immune status immediately. A quiet eye can conceal destructive retinitis.
Working copy · review pending
Chapter 169
Localise inflammation and assess immune status before selecting tests and treatment. Infection and a quiet-looking eye can coexist.
Working copy · review pending
Chapter 219
A quiet-looking eye can harbour inflammation; a presumed uveitis can also conceal tumour or infection.
Working copy · review pending
Chapter 228
Vitreous-predominant inflammation that is defined by its anatomical site, often presents with floaters in a quiet eye, and is diagnosed late.
Working copy · review pending
Chapter 230
Descriptive 'white-dot' labels are imprecise; a pathology-based classification and a structured diagnostic roadmap are preferred.
Working copy · review pending
Chapter 022
Neurological and mechanical causes, from the first examination to relief of diplopia.
Working copy · review pending
Chapter 028
Visual loss requires a rigorous, systematic and methodical approach. A detailed history is the foundation; it is followed by the complete five-part optic nerve function assessment. The findings generate a differential diagnosis, and only then are targeted investigations selected. Normal visual acuity or an unremarkable fundus does not exclude organic disease; the absence of a relative afferent pupillary defect (RAPD) alone is not a positive functional diagnosis.
Working copy · review pending
Chapter 034
Describe the slow phase, establish onset and assess ocular and neurological findings. Early-onset nystagmus is not a single disease, and new symptoms deserve reassessment.
Working copy · review pending
Chapter 038
A detailed history and five examination pillars connect symptoms to a differential diagnosis. Urgent warning signs take priority over a rigid routine sequence.
Working copy · review pending
Chapter 041
Localise the defect, recognise emergencies and confirm the cause with imaging.
Working copy · review pending
Chapter 051
Demonstrate preserved visual function positively, investigate plausible comorbidity and explain the diagnosis respectfully.
Working copy · review pending
Chapter 056
Combine the history with acuity, colour, pupils, disc appearance and visual fields.
Working copy · review pending
Chapter 061
Separate an obvious ocular cause from a normal-looking eye, then use the history, fixation, VOR and OKN to choose the next test.
Working copy · review pending
Chapter 064
Triage the dangerous causes first, then recognise common neuro-ophthalmic syndromes without over-investigating.
Working copy · review pending
Chapter 069
Motility patterns guide a differential diagnosis, but do not establish a cause on their own. Combine history, passive movement, neurological examination and orbital imaging.
Working copy · review pending
Chapter 070
Localise a deficit clinically, then select imaging that answers the suspected anatomical question. OCT complements visual function and neuroimaging; no colour map or isolated sign establishes a diagnosis.
Working copy · review pending
Chapter 071
Localise a deficit clinically, then select imaging that answers the suspected anatomical question. OCT complements visual function and neuroimaging; no colour map or isolated sign establishes a diagnosis.
Working copy · review pending
Chapter 072
Adult strabismus is often incomitant and needs a structured motility examination before anyone calls it cosmetic. Separate monocular from binocular diplopia, localise the level, and treat a new third-nerve palsy as an emergency until vascular imaging and inflammatory work-up are settled.
Working copy · review pending
Chapter 093
First describe the phenomenon and assess basic vision, then test recognition, attention and visually guided action. The pattern and time course guide investigation.
Working copy · review pending
Chapter 097
Choose a field test the patient can perform, inspect its reliability and pattern, then use selected retinal or cortical recordings to answer the remaining question.
Working copy · review pending
Chapter 107
Recovery of sight does not exclude retinal ischaemia, giant cell arteritis or an intracranial cause. History directs urgent assessment.
Working copy · review pending
Chapter 148
Trace the pathway before interpreting a structural abnormality.
Working copy · review pending
Chapter 149
Match symptoms, pupils, visual fields, OCT and selected electrical tests.
Working copy · review pending
Chapter 150
Use anatomy to choose and interpret OCT, MRI and CT.
Working copy · review pending
Chapter 152
Use anatomy to choose and interpret OCT, MRI and CT.
Working copy · review pending
Chapter 153
Check vision, pupils, disc and blood pressure first. The pattern and speed of change determine which brain or vascular imaging cannot wait.
Working copy · review pending
Chapter 154
Check vision, pupils, disc and blood pressure first. The pattern and speed of change determine which brain or vascular imaging cannot wait.
Working copy · review pending
Chapter 155
Inspect the raw scan before reading the colour map. Compare retinal layers with visual function, time since onset and the suspected lesion.
Working copy · review pending
Chapter 163
Assess urgency first, then combine acuity, colour, pupils, disc and fields to localise the problem.
Working copy · review pending
Chapter 164
Assess urgency first, then combine acuity, colour, pupils, disc and fields to localise the problem.
Working copy · review pending
Chapter 229
Choose a field test the patient can perform, inspect its reliability and pattern, then use selected retinal or cortical recordings to answer the remaining question.
Working copy · review pending
Chapter 037
Interpret the disc together with visual function, refraction and the child’s development. A recognizable structural anomaly does not exclude a second ocular or systemic problem.
Working copy · review pending
Chapter 040
Choose a procedure for the motility pattern while protecting sclera, circulation and sensory function. This is surgical teaching, not a stand-alone operative manual.
Working copy · review pending
Chapter 043
Balance visual development, surgical risk and lifelong follow-up.
Working copy · review pending
Chapter 050
Measure near and distance deviation, assess control and binocular function, and select treatment for the individual subtype.
Working copy · review pending
Chapter 052
Adapt the examination to the child, test sensory function and measure alignment with a clearly documented method.
Working copy · review pending
Chapter 054
Assess development, visual input and binocular function before selecting treatment.
Working copy · review pending
Chapter 073
The eye often shows systemic disease before the underlying diagnosis is known. Read the ocular sign, then ask which systemic condition it fits, which examination confirms it and which referral cannot wait.
Working copy · review pending
Chapter 078
Check monocular vision, ocular health, motility and cycloplegic refraction. The near–distance pattern and response to glasses guide treatment; acute or atypical signs need neurological assessment.
Working copy · review pending
Chapter 098
A small angle is a motor finding. Central suppression with peripheral fusion is a sensory pattern. Establish both before choosing a diagnostic label or treatment.
Working copy · review pending
Chapter 132
Build trust, assess vision and binocular function, then make reproducible measurements before choosing treatment.
Working copy · review pending
Chapter 027
Distinguish tear production, impaired drainage and inflammation; integrate findings before choosing an intervention.
Working copy · review pending
Chapter 031
Assess lash disorders, entropion, dermatitis, infection and meibomian gland dysfunction separately. This complete working copy retains the original topics and corrects confusion between the gray line and mucocutaneous junction.
Working copy · review pending
Chapter 032
Describe a skin lesion, assess its risk and plan tissue sampling accordingly. Anatomy, histology and clinical course work together; no single feature proves that a lesion is benign.
Working copy · review pending
Chapter 036
Begin with morphology, evolution and warning signs, then choose observation, histology or treatment. Similar-looking lid lesions can require very different pathways.
Working copy · review pending
Chapter 042
Identify the anatomical cause before choosing a corrective operation.
Working copy · review pending
Chapter 045
Recognise sight-threatening disease before choosing anti-inflammatory or rehabilitative treatment.
Working copy · review pending
Chapter 057
Assess lid position, levator function, laxity and corneal protection together.
Working copy · review pending
Chapter 058
Establish the lesion and its extent, then plan tumour control and protection of the eye together.
Working copy · review pending
Chapter 059
A broad clinical review of inflammatory, cystic, benign and malignant lesions, lashes and lid position.
Working copy · review pending
Chapter 065
Separate the common inflammatory eyelid problem from the lesion that can hide a malignancy, and know which findings need biopsy.
Working copy · review pending
Chapter 076
Anatomy earns its place at the bedside: it predicts which compartment a lesion occupies, which nerve or sinus is at risk and which finding cannot wait. Measure, image and examine the optic nerve before calling a proptosis cosmetic.
Working copy · review pending
Chapter 077
Painful restricted movements, proptosis or visual dysfunction with swollen lids should trigger urgent assessment for orbital infection. Distinguish this from preseptal disease and from non-infectious orbital inflammation before choosing treatment.
Working copy · review pending
Chapter 171
Identify the anatomical cause before choosing a corrective operation.
Working copy · review pending
Chapter 172
Anatomy earns its place at the bedside: it predicts which compartment a lesion occupies, which nerve or sinus is at risk and which finding cannot wait. Measure, image and examine the optic nerve before calling a proptosis cosmetic.
Working copy · review pending
Chapter 193
Distinguish tear production, impaired drainage and inflammation; integrate findings before choosing an intervention.
Working copy · review pending
Chapter 194
Establish the cause and tumour risk before selecting evisceration, enucleation or exenteration.
Working copy · review pending
Chapter 195
Separate lid laxity and inflammation from a lesion that needs histological diagnosis.
Working copy · review pending
Chapter 198
Identify the anatomical cause before choosing a corrective operation.
Working copy · review pending
Chapter 222
A complete teaching draft on periocular reconstruction: lamellar anatomy, graft and flap vascularity, upper and lower lid defects, the medial canthus, scar modulation and oncologic sequencing. Original numerical examples are retained as qualified historical teaching, not as universal rules or a drug recipe. Primary sources, current guideline text, product labels and dictionary entries were not read for this candidate and remain pending.
Working copy · review pending
Chapter 016
Check image quality, locate the abnormality, then connect it with symptoms, examination and change over time.
Working copy · review pending
Chapter 089
Read the complete scan in clinical context. Locate each finding by layer, check artefacts and segmentation, then decide what it changes for diagnosis or treatment.
Working copy · review pending
Chapter 090
Read the complete scan in clinical context. Locate each finding by layer, check artefacts and segmentation, then decide what it changes for diagnosis or treatment.
Working copy · review pending
Chapter 091
Read the complete scan in clinical context. Locate each finding by layer, check artefacts and segmentation, then decide what it changes for diagnosis or treatment.
Working copy · review pending
Chapter 131
Check image quality, locate the abnormality, then connect it with symptoms, examination and change over time.
Working copy · review pending
Chapter 210
Match the clinical question to global retinal, focal macular, ganglion-cell or RPE testing. Reproducible recording and appropriate reference values matter as much as the waveform name.
Working copy · review pending
Chapter 066
Seven teaching cases connect surface injury, haemorrhage, chemical burns and open-globe repair. Treatment follows injury depth and risk, rather than a single standard recipe.
Working copy · review pending
Chapter 068
Seven teaching cases connect surface injury, haemorrhage, chemical burns and open-globe repair. Treatment follows injury depth and risk, rather than a single standard recipe.
Working copy · review pending
Chapter 096
The mechanism, globe integrity and associated retinal injury determine urgency. Primary closure and later retinal surgery are different decisions.
Working copy · review pending
Chapter 120
The mechanism, globe integrity and associated retinal injury determine urgency. Primary closure and later retinal surgery are different decisions.
Working copy · review pending
Chapter 035
Begin with urgency, then connect symptoms, tests and patient goals. Source conversation fragments illustrate communication; they are not verified treatment protocols.
Working copy · review pending
Chapter 060
Use short, respectful phrases, explain findings with their limits and close the loop on medicines and follow-up.
Working copy · review pending
Chapter 140
Use simple patient language and precise documentation without inventing findings from a shorthand note or a damaged quotation.
Working copy · review pending
Chapter 157
The eye often shows systemic disease before the underlying diagnosis is known. Read the ocular sign, then ask which systemic condition it fits, which examination confirms it and which referral cannot wait.
Working copy · review pending
Chapter 158
The eye often shows systemic disease before the underlying diagnosis is known. Read the ocular sign, then ask which systemic condition it fits, which examination confirms it and which referral cannot wait.
Working copy · review pending